pimobendan has been researched along with saterinone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eschenhagen, T; Mende, U; Müller, FU; Neumann, J; Schmitz, W; Scholz, H | 1 |
Mende, U; Meyer, W; Neumann, J; Nose, M; Schmitz, W; Scholz, H; Starbatty, J; Stein, B; von der Leyen, H; Wenzlaff, H | 1 |
2 other study(ies) available for pimobendan and saterinone
Article | Year |
---|---|
Phosphodiesterase inhibition and positive inotropy in failing human myocardium.
Topics: Benzimidazoles; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Heart; Humans; Imidazoles; Isoenzymes; Isometric Contraction; Isoproterenol; Myocardial Contraction; Myocardium; Organ Culture Techniques; Oxindoles; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Pyridazines; Pyridones | 1992 |
Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Benzimidazoles; Calcium; Cardiac Output, Low; Cardiotonic Agents; Cyclic AMP; Female; Heart; Humans; Imidazoles; In Vitro Techniques; Isoenzymes; Male; Middle Aged; Myocardial Contraction; Myocardium; Ouabain; Oxindoles; Phosphodiesterase Inhibitors; Piperazines; Pyridazines; Pyridones | 1991 |